FibroBiologics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | – | +364.9% | +31.1% | +45.2% | |
| – | – | – | – | – | – | |
| – | -22.1% | +120.2% | +106.5% | +90.2% | +64.5% | |
| – | +111.4% | +214.1% | +96.4% | +41.6% | +0.1% | |
| – | +35.0% | +183.1% | +99.0% | +54.5% | +15.1% | |
| – | – | – | – | – | – | |
| – | – | +16,250.0% | -77.5% | -86.4% | +920.0% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.